Eiger Biopharmaceuticals (EIGR)
NASDAQ:EIGR
Holding EIGR?
Track your performance easily

Eiger Biopharmaceuticals (EIGR) Stock Forecast & Price Target

592 Followers
See the Price Targets and Ratings of:

EIGR Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Eiger
Biopharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EIGR Stock 12 Month Forecast

There Are No Analyst Ratings for EIGR In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

EIGR Financial Forecast

EIGR Earnings Forecast

The previous quarter’s earnings for EIGR were -$9.09.
The previous quarter’s earnings for EIGR were -$9.09.

EIGR Sales Forecast

The previous quarter’s earnings for EIGR were $3.80M.
The previous quarter’s earnings for EIGR were $3.80M.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ladenburg Thalmann & Co.
$30
Buy
1639.13%
Upside
Reiterated
11/10/23
Analysts Have Conflicting Sentiments on These Healthcare Companies: Rain Therapeutics (NASDAQ: RAIN), Arcadia Biosciences (NASDAQ: RKDA) and Eiger Biopharmaceuticals (NASDAQ: EIGR)
Citi
$90
Buy
5117.39%
Upside
Reiterated
08/29/23
Citi Sticks to Their Buy Rating for Eiger Biopharmaceuticals (EIGR)

Best Analysts Covering Eiger Biopharmaceuticals

Which Analyst Should I Follow If I Want to Buy EIGR and Sell After:
1 Month
xxx
Success Rate
14/31 ratings generated profit
45%
Average Return
+0.56%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 45.16% of your transactions generating a profit, with an average return of +0.56% per trade.
3 Months
xxx
Success Rate
13/31 ratings generated profit
42%
Average Return
-11.53%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.94% of your transactions generating a profit, with an average return of -11.53% per trade.
1 Year
Michael HigginsLadenburg Thalmann & Co.
Success Rate
4/31 ratings generated profit
13%
Average Return
-40.60%
reiterated a buy rating 12 months ago
Copying Michael Higgins's trades and holding each position for 1 Year would result in 12.90% of your transactions generating a profit, with an average return of -40.60% per trade.
2 Years
xxx
Success Rate
1/31 ratings generated profit
3%
Average Return
-58.93%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 3.23% of your transactions generating a profit, with an average return of -58.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EIGR Analyst Recommendation Trends

Rating
Jun 23
Aug 23
Sep 23
Nov 23
Apr 24
Strong Buy
5
6
6
5
3
Buy
0
0
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
6
6
5
4
In the current month, EIGR has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. EIGR average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

EIGR Stock Forecast FAQ

What is EIGR’s average 12-month price target, according to analysts?
Currently, no data Available
What is EIGR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for EIGR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is EIGR a Buy, Sell or Hold?
      Currently, no data Available
      What is Eiger Biopharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about Eiger Biopharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of EIGR?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis